Home A new polymorph of 1-(4-nitrophenyl)-1H-benzimidazole (C13H9N3O2)
Article Open Access

A new polymorph of 1-(4-nitrophenyl)-1H-benzimidazole (C13H9N3O2)

  • Halliru Ibrahim , Sizwe J. Zamisa ORCID logo EMAIL logo , Muhammad D. Bala ORCID logo and Holger B. Friedrich
Published/Copyright: November 8, 2021
Download Article (PDF)
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Zeitschrift für Kristallographie - New Crystal Structures
From the journal Zeitschrift für Kristallographie - New Crystal Structures Volume 237 Issue 1

Abstract

C13H9N3O2, monoclinic, P21/c (no. 14), a = 3.7375(1) Å, b = 27.9680(6) Å, c = 10.2595(2) Å, β = 95.5120(10)°, V = 1067.47(4) Å3, Z = 4, R gt (F) = 0.0370, wR ref (F 2) = 0.0975, T = 100 K.

CCDC no.: 1565535

The crystal structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Block, colourless
Size: 0.35 × 0.22 × 0.14 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.11 mm−1
Diffractometer, scan mode: Bruker APEX-II, φ and ω-scans
θ max, completeness: 28.5°, >99%
N(hkl)measured, N(hkl)unique, R int: 16,686, 2678, 0.022
Criterion for I obs, N(hkl)gt: I obs > 2 σ(I obs), 2340
N(param)refined: 163
Programs: Bruker programs [1], SHELX [2, 3], Mercury [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

x y z U iso*/U eq
O1 0.5825 (3) 0.23558 (3) −0.28700 (10) 0.0359 (3)
O2 0.4120 (3) 0.29322 (3) −0.41760 (9) 0.0307 (2)
N1 0.5643 (3) 0.27807 (4) −0.31499 (10) 0.0190 (2)
N2 1.1115 (3) 0.40974 (3) 0.06625 (9) 0.0142 (2)
N3 1.3137 (3) 0.48000 (3) 0.15102 (10) 0.0168 (2)
C1 0.7257 (3) 0.31238 (4) −0.21878 (11) 0.0150 (2)
C6 0.9016 (3) 0.29518 (4) −0.10301 (11) 0.0157 (2)
H6 0.928437 0.261777 −0.088348 0.019*
C5 1.0370 (3) 0.32772 (4) −0.00933 (11) 0.0148 (2)
H5 1.161927 0.316828 0.070135 0.018*
C4 0.9892 (3) 0.37661 (4) −0.03204 (10) 0.0137 (2)
C8 1.0857 (3) 0.40654 (4) 0.20120 (11) 0.0141 (2)
C9 1.2102 (3) 0.45074 (4) 0.25120 (11) 0.0153 (2)
C10 1.2101 (3) 0.46071 (4) 0.38404 (12) 0.0188 (2)
H10 1.290473 0.490731 0.418927 0.023*
C11 1.0890 (3) 0.42547 (4) 0.46370 (11) 0.0199 (2)
H11 1.089811 0.431278 0.554958 0.024*
C2 0.6871 (3) 0.36085 (4) −0.24519 (11) 0.0159 (2)
H2 0.572419 0.371569 −0.326602 0.019*
C3 0.8191 (3) 0.39332 (4) −0.15052 (11) 0.0151 (2)
H3 0.794037 0.426691 −0.166046 0.018*
C13 0.9582 (3) 0.37116 (4) 0.27998 (11) 0.0168 (2)
H13 0.870739 0.341494 0.244845 0.020*
C12 0.9652 (3) 0.38140 (4) 0.41247 (11) 0.0189 (2)
H12 0.884150 0.357961 0.469864 0.023*
C7 1.2482 (3) 0.45461 (4) 0.04498 (11) 0.0158 (2)
H7 1.290807 0.465953 −0.039429 0.019*

Source of material

The title compound was synthesized according to literature [5]. Colourless, block crystals were obtained by slow evaporation of its dichloromethane solution.

Experimental details

Crystal evaluation and data collection were done on a Bruker Smart APEX2 diffractometer [1]. The structure was solved by the direct method using the SHELXS [2] program. The visual crystal structure information was performed using MERCURY [4] system software. All C–Haromatic bond distances were restrained to 0.95 Å with U iso(Haromatic) = 1.2U eq of the parent atom.

Discussion

N-substituted azoles bearing imidazole or benzimidazole have generated attention as common heterocyclic moieties in various pharmaceutical compounds [6]. Their mode of synthesis includes incorporating an azole ring into the framework of a pharmaceutical candidate compound [7, 8] and following advanced protocols to achieve more stereo- and regio-selective control of the product [9]. A greener route to N-substituted azoles is to alkylate/arylate the azole nitrogen with appropriate electrophiles, such as alkyl halides [1, 10, 11]. This involves basic deprotonation of the N atom in a suitable aprotic solvent and subsequent nucleophilic displacement of the halide from the alkyl halide. Polymorphs of N-substituted azoles are rare [12], [13], [14]. However, solid state structural study of the different crystalline forms of available compounds is important especially, due to the variety of the biological and pharmacological activities of different polymorphs [15].

The title compound crystallizes in the P21/c space group and is a polymorph of the C2/c -type structure (CCDC number: 1565535; CSD refcode: PESNEJ) [16]. The new polymorph reported herein consists of one molecule in the asymmetric unit compared to the former which has two. Though the magnitude of the b axis in the new polymorph (27.9680(6) Å) is significantly larger than that of the former (7.1422(8) Å), the other unit cell dimensions of the new polymorph are much smaller than those of PESNEJ. Hence, the new polymorph has a lower unit cell volume (1067.47(4) Å3) and a higher packing coefficient (0.738) than the former (cell volume = 1067.47(4) Å3; packing coefficient = 0.719). The molecular geometries of the two polymorphs are similar based on the root mean square deviation values (0.0576–0.0680 Å) obtained from the molecular overlays. This is an indication that intermolecular interactions are solely responsible for the formation of the different polymorphs. In the title compound, intermolecular C–H⃛N hydrogen bonds with the R 2 2 ( 6 ) graph set descriptor were found between the H7 and N3 atoms of neighbouring benzimidazolyl moieties (C7⃛N3 = 3.271(2) Å, H7⃛N3 = 2.471(1) Å, C7–H7⃛N3 = 142°, symmetry code: 3−x, 1−y, −z). Furthermore, intermolecular π⃛π interactions were observed in the title structure between the neighbouring benzimidazolyl units (π benzimidazolyl⃛π benzimidazolyl = 3.737 Å, symmetry code: 1+x, y, z). Interestingly, these two types of intermolecular interactions were not observed in the literatre known C2/c-type structure.

Corresponding author: Sizwe J. Zamisa, School of Chemistry and Physics, University of KwaZulu-Natal, Private Bag X54001, Westville Campus, Westville, 4000 Durban, South Africa, E-mail:

Funding source: University of KwaZulu-Natal

Funding source: National Research Foundation http://dx.doi.org/10.13039/501100001321

Acknowledgement

HI thanks FCET Gusau.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This study was financially supported by University of KwaZulu-Natal and the National Research Foundation (NRF).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Bruker. APEXII; Bruker AXS Inc: Madison, Wisconsin, USA, 2009.Search in Google Scholar

2. Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. A 2008, A64, 112–122; https://doi.org/10.1107/s0108767307043930.Search in Google Scholar

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar

4. Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J., Wood, P. A. Mercury CSD 2.0-new features for the visualization and investigation of crystal structures. J. Appl. Crystallogr. 2008, 41, 466–470; https://doi.org/10.1107/s0021889807067908.Search in Google Scholar

5. Lee, H. M., Lu, C. Y., Chen, C. Y., Chen, W. L., Lin, H. C., Chiu, P. L., Cheng, P. Y. Palladium complexes with ethylene-bridged bis(N-heterocyclic carbene) for C–C coupling reactions. Tetrahedron 2004, 60, 5807–5825; https://doi.org/10.1016/j.tet.2004.04.070.Search in Google Scholar

6. Menge, W. M. P. B., Timmerman, H. Substituted imidazoles, the key to histaminergic receptors. In Pharmacochemistry Library; Leurs, R., Timmerman, H., Eds.; Elsevier: Amsterdam, Netherlands, 1998; pp. 145–158.10.1016/S0165-7208(98)80028-7Search in Google Scholar

7. Green, G., Evans, J., Vong, A., Katritzky, A., Rees, C., Scriven, E. Comprehensive Heterocyclic Chemistry II; Pergamon Press: Oxford, 1995; p. 469.Search in Google Scholar

8. Taylor, A. P., Robinson, R. P., Fobian, Y. M., Blakemore, D. C., Jones, L. H., Fadeyi, O. Modern advances in heterocyclic chemistry in drug discovery. Org. Biomol. Chem. 2016, 14, 6611–6637; https://doi.org/10.1039/c6ob00936k.Search in Google Scholar

9. Xi, N., Xu, S., Cheng, Y., Tasker, A. S., Hungate, R. W., Reider, P. J. Regio-controlled synthesis of N-substituted imidazoles. Tetrahedron Lett. 2005, 46, 7315–7319; https://doi.org/10.1016/j.tetlet.2005.08.138.Search in Google Scholar

10. Ibrahim, H., Bala, M. D., Omondi, B. 1-[4-(1H-imidazol-1-yl)phenyl]ethanone monohydrate. Acta Crystallogr. 2012, 68, o2305; https://doi.org/10.1107/s1600536812029157.Search in Google Scholar

11. Ibrahim, H., Bala, M. D. 1-(4-Nitrophenyl)-1H-imidazol-3-ium chloride. Acta Crystallogr. 2013, E69, o114; https://doi.org/10.1107/s1600536812050878.Search in Google Scholar

12. Albelo, L. M. R., Ruiz-Salvador, A. R., Lewis, D. W., Gómez, A., Mialane, P., Marrot, J., Dolbecq, A., Sampieri, A., Mellot-Draznieks, C. Zeolitic polyoxometalates metal organic frameworks (Z-POMOF) with imidazole ligands and ε-Keggin ions as building blocks; computational evaluation of hypothetical polymorphs and a synthesis approach. Phys. Chem. Chem. Phys. 2010, 12, 8632–8639; https://doi.org/10.1039/c004234j.Search in Google Scholar

13. Karaseva, I., Karasev, M., Kurbatova, S. Structure and polymorphism of imidazole derivatives. Russ. J. Phys. Chem. A 2021, 95, 119–126; https://doi.org/10.1134/s0036024421010118.Search in Google Scholar

14. Desiraju, G. R. crystal engineering: a holistic view. Angew. Chem. 2007, 46, 8342–8356; https://doi.org/10.1002/anie.200700534.Search in Google Scholar

15. Aljamali, N. M., Alsabri, I. K. A. Development of trimethoprim drug and innovation of sulfazane-trimethoprim derivatives as anticancer agents. Biomed. Pharmacol. J. 2020, 13, 613–625; https://doi.org/10.13005/bpj/1925.Search in Google Scholar

16. Garcia-Aranda, M. I., Gomez-Castro, C. Z., Garcia-Baez, E. V., Gomez, Y. G., Castrejon-Flores, J. L., Padilla-Martinez, I. I. Acta Crystallogr. 2018, C74, 428.Search in Google Scholar
Received: 2021-09-15
Accepted: 2021-10-22
Published Online: 2021-11-08
Published in Print: 2022-02-23

© 2021 Halliru Ibrahim et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of (E)-7-hydroxy-2-((6-methoxypyridin-3-yl)methylene)-3, 4-dihydronaphthalen-1(2H)-one, C17H15NO3
  4. Crystal structure of (E)-7-methoxy-2-((2-methoxypyridin-3-yl)methylene)-3,4-dihydronaphthalen-1 (2H)-one, C18H17NO3
  5. The crystal structure of N 6,N 6′-di(pyridin-2-yl)-[2,2′-bipyridine]-6,6′-diamine, C20H16N6
  6. The crystal structure of {N 1,N 2-bis[2,4-dimethyl-6-(4-(tert-butyl)phenyl)(phenyl)methyl]acenaphthylene-1,2-diimino-κ2 N, N′}-dibromido-nickel(II) – dichloromethane(1/2), C64H64Br2Cl4N2Ni
  7. Synthesis and crystal structure of nonacarbonyltris[(2-thia-1,3,5-triaza-7-phosphatricylco[3.3.1.1]decane-κ1 P)-2,2-dioxide]triruthenium(0) – acetonitrile (7/6), C25.71H32.57N9.86O15P3S3Ru3
  8. A new polymorph of 1-(4-nitrophenyl)-1H-benzimidazole (C13H9N3O2)
  9. The crystal structure of 2,2′-((1E,1′E)-(naphthalene-2,3 diylbis(azanylylidene)) bis(methanylylidene))bis(4-methylphenol), C26H22N2O2
  10. The crystal structure of bis(μ2-iodido)-bis(η6-benzene)-bis(iodido)-diosmium(II), C12H12I4Os2
  11. Redetermination of the crystal structure of bis{hydridotris(3,5-dimethylpyrazol-1-yl-κN 3)borato}copper(II), C30H44B2CuN12
  12. Crystal structure of (E)-3-((4-(tert-butyl)phenyl)thio)-4-hydroxypent-3-en-2-one, C15H20O2S
  13. Crystal structure of 2,2′-(p-tolylazanediyl)bis(1-phenylethan-1-one), C23H21NO2
  14. Redetermination of the crystal structure of the crystal sponge the poly[tetrakis(μ3-2,4,6-tris(pyridin-4-yl)-1,3,5-triazine)-dodecaiodidohexazinc(II) nitrobenzene solvate], C72H48I12N24Zn6⋅10(C6H5NO2)
  15. Crystal structure of (4′E)-6′-(diethylamino)-2-[(E)-[(6-methylpyridin-2-yl)methylidene]amino]-4′-{2-[(2E)-1,3,3-trimethyl-2,3-dihydro-1H-indol-2-ylidene]ethylidene}-1′,2,2′,3,3′,4′-hexahydrospiro[isoindole-1,9′-xanthene]-3-one, C44H45N5O2
  16. Crystal structure of (E)-7-fluoro-2-(3-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C17H12F2O1
  17. Crystal structure of tetrabutylammonium sulfanilate – 1-(diaminomethylene)thiourea (1/2)
  18. Crystal structure of [2,2′-{azanediyl)bis[(propane-3,1-diyl)(azanylylidene)methylylidene]} bis(3,5-dichlorophenolato)-κ2O,O′]-isothiocyanato-κN-iron(III), C21H19Cl4FeN4O2S
  19. Crystal structure of (4-chlorophenyl)(4-hydroxyphenyl)methanone, C13H9ClO2
  20. Crystal structure of 6,6′-((pentane-1,3-diylbis(azaneylylidene))bis(methaneylylidene))bis(2,4-dibromolphenolato-κ4 N,N′,O,O′)copper(II),) C19H16Br4CuN2O2
  21. Chlorido-(2,2′-(ethane-bis(5-methoxyphenolato))-κ4 N,N′,O,O′)manganese(III) monohydrate, C19H18Cl2CuN2O2
  22. Crystal structure of 2,6-di-tert-butyl-4-(4-methoxybenzylidene)cyclohexa-2,5-dien-1-one, C22H28O2
  23. Crystal structure of [6,6′-(((2,2-dimethylpropane-1,3-diyl)bis(azanylylidene))bis(methanylylidene))bis(2-chlorophenolato)-κ4N,N′,O,O′]copper(II)
  24. Crystal structure of 2-chloro-3-((thiophen-2-ylmethyl)amino)naphthalene-1,4-dione, C30H20O4N2Cl2S2
  25. Crystal structure of bis{hydridotris(3-trifluoromethyl-5-methylpyrazolyl-1-yl)borato-κN 3}manganese(II), C30H26B2F18MnN12
  26. Crystal structure of 1-(2-methylphenyl)-2-(2-methylbenzo[b]thienyl)-3,3,4,4,5,5-hexafluorocyclopent-ene, C21H14F6S
  27. Crystal structure of 2-(3-((carbamimidoylthio)methyl)benzyl)isothiouronium hexafluorophosphate monohydrate, C10H17F6N4OPS2
  28. Crystal structure of 4,5-diiodo-1,3-dimesityl-1H-1,2,3-triazol-3-ium chloride – chloroform (1/1), C21H23Cl4I2N3
  29. Crystal structure of azido-k1 N-{6,6′-((((methylazanediyl)bis(propane-3,1-diyl))bis(azanylylidene))bis(methanylylidene))bis(2,4-dibromophenolato)k5 N,N′,N″,O,O′}cobalt(III)-methanol (1/1)), C21H23Br4CoN6O3
  30. The crystal structure of 2-(4-((carbamimidoylthio)methyl)benzyl)isothiouronium hexafluorophosphate monohydrate, C10H17F6N4OPS2
  31. Crystal structure of 1,1′-(methane-1,1-diyl)bis(3-methyl-1H-imidazol-3-ium) bis(hexafluoridophosphate), C9H14F12N4P2
  32. Crystal structure of (4′E)-6′-(diethylamino)-2-[(E)-[(pyren-1-yl)methylidene]amino]-4′-{2-[(2E)-1,3,3-trimethyl-2,3-dihydro-1H-indol-2-ylidene]ethylidene}-1′,2,2′,3,3′,4′-hexahydrospiro[isoindole-1,9′-xanthene]-3-one, C54H48N4O2
  33. Crystal structure of poly[bis(μ2-2,6-bis(1-imidazoly)pyridine-κ2 N,N′)-bis(thiocyanato-κ1 N)copper(II)] dithiocyanate, C24H18CuN12S2
  34. Cones with a three-fold symmetry constructed from three hydrogen bonded theophyllinium cations that coat [FeCl4]− anions in the crystal structure of tris(theophyllinium) bis(tetrachloridoferrate(III)) chloride trihydrate, C21H33Cl9Fe2N12O9
  35. Crystal structure of 14-O-[(4-(4-hydroxypiperidine-1-yl)-6-methylpyrimidine-2-yl)thioacetyl]-mutilin monohydrate, C32H49N3O6S
  36. The crystal structure of (E)-3-chloro-2-(2-(4-methylbenzylidene)hydrazinyl)pyridine, C13H12ClN3
  37. The crystal structure of 4-phenyl-4-[2-(pyridine-4-carbonyl)hydrazinylidene]butanoic acid, C16H15N3O3
  38. The crystal structure of 6-amino-5-carboxypyridin-1-ium pentaiodide monohydrate C6H9I5N2O3
  39. Crystal structure of bis(μ3-oxido)-bis(μ2-2-formylbenzoato-k2O:O′)-bis(2-(dimethoxymethyl)-benzoato-κO)-oktakismethyl-tetratin(IV)
  40. Crystal structure of 2-((E)-(((E)-2-hydroxy-4-methylbenzylidene) hydrazineylidene)methyl)-4-methylphenol, C16H16N2O2
  41. Crystal structure of (E)-amino(2-((5-methylfuran-2-yl)methylene)hydrazinyl) methaniminium nitrate monohydrate, C14H26N10O10
  42. The crystal structure of N′-(2-chloro-6-hydroxybenzylidene)thiophene-2-carbohydrazide monohydrate, C12H11ClN2O3S
  43. Crystal structure of catena-poly[(μ2-1,1′-(biphenyl-4,4′-diyl)bis(1H-imidazol)-κ2N:N′)-bis(4-bromobenzoate-κ1O)zinc(II)], C64H44Br4N8O8Zn2
  44. The crystal structure of catena-poly[(1-(4-carboxybenzyl)pyridin-1-ium-4-carboxylato-κ1O)-(μ2-oxalato-κ4 O:O′:O″:O‴)dioxidouranium(VI)], C16H11NO10U
  45. Crystal structure of 3-allyl-4-(2-bromoethyl)-5-(4-methoxyphenyl)-2-phenylfuran, C22H21BrO2
  46. Halogen bonds in the crystal structure of 4,3′:5′,4″-terpyridine — 1,3-diiodotetrafluorobenzene (1/1), C21H11F4I2N3
  47. Crystal structure of 2-(1H-indol-3-yl)ethan-1-aminium 2-(4-acetylphenoxy)acetate, C20H22N2O4
  48. Chalcogen bonds in the crystal structure of 4,7-dibromo-2,1,3-benzoselenadiazole, C6H2Br2N2Se
  49. The crystal structure of 1,4-bis((1H-benzimidazol-2-yl)methyl)-piperazine-2,5-dione dihydrate, C20H22N6O4
  50. The crystal structure of C19H20O8
  51. The crystal structure of KNa3Te8O18·5H2O exhibiting a ∞2[Te4O9]2− layer
  52. Erratum
  53. Erratum to: Crystal structure of (Z)-3-(6-bromo-1H-indol-3-yl)-1,3-diphenylprop-2-en-1-one, C23H16BrNO
https://doi.org/10.1515/ncrs-2021-0360
Creative Commons
BY 4.0

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of (E)-7-hydroxy-2-((6-methoxypyridin-3-yl)methylene)-3, 4-dihydronaphthalen-1(2H)-one, C17H15NO3
  4. Crystal structure of (E)-7-methoxy-2-((2-methoxypyridin-3-yl)methylene)-3,4-dihydronaphthalen-1 (2H)-one, C18H17NO3
  5. The crystal structure of N 6,N 6′-di(pyridin-2-yl)-[2,2′-bipyridine]-6,6′-diamine, C20H16N6
  6. The crystal structure of {N 1,N 2-bis[2,4-dimethyl-6-(4-(tert-butyl)phenyl)(phenyl)methyl]acenaphthylene-1,2-diimino-κ2 N, N′}-dibromido-nickel(II) – dichloromethane(1/2), C64H64Br2Cl4N2Ni
  7. Synthesis and crystal structure of nonacarbonyltris[(2-thia-1,3,5-triaza-7-phosphatricylco[3.3.1.1]decane-κ1 P)-2,2-dioxide]triruthenium(0) – acetonitrile (7/6), C25.71H32.57N9.86O15P3S3Ru3
  8. A new polymorph of 1-(4-nitrophenyl)-1H-benzimidazole (C13H9N3O2)
  9. The crystal structure of 2,2′-((1E,1′E)-(naphthalene-2,3 diylbis(azanylylidene)) bis(methanylylidene))bis(4-methylphenol), C26H22N2O2
  10. The crystal structure of bis(μ2-iodido)-bis(η6-benzene)-bis(iodido)-diosmium(II), C12H12I4Os2
  11. Redetermination of the crystal structure of bis{hydridotris(3,5-dimethylpyrazol-1-yl-κN 3)borato}copper(II), C30H44B2CuN12
  12. Crystal structure of (E)-3-((4-(tert-butyl)phenyl)thio)-4-hydroxypent-3-en-2-one, C15H20O2S
  13. Crystal structure of 2,2′-(p-tolylazanediyl)bis(1-phenylethan-1-one), C23H21NO2
  14. Redetermination of the crystal structure of the crystal sponge the poly[tetrakis(μ3-2,4,6-tris(pyridin-4-yl)-1,3,5-triazine)-dodecaiodidohexazinc(II) nitrobenzene solvate], C72H48I12N24Zn6⋅10(C6H5NO2)
  15. Crystal structure of (4′E)-6′-(diethylamino)-2-[(E)-[(6-methylpyridin-2-yl)methylidene]amino]-4′-{2-[(2E)-1,3,3-trimethyl-2,3-dihydro-1H-indol-2-ylidene]ethylidene}-1′,2,2′,3,3′,4′-hexahydrospiro[isoindole-1,9′-xanthene]-3-one, C44H45N5O2
  16. Crystal structure of (E)-7-fluoro-2-(3-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C17H12F2O1
  17. Crystal structure of tetrabutylammonium sulfanilate – 1-(diaminomethylene)thiourea (1/2)
  18. Crystal structure of [2,2′-{azanediyl)bis[(propane-3,1-diyl)(azanylylidene)methylylidene]} bis(3,5-dichlorophenolato)-κ2O,O′]-isothiocyanato-κN-iron(III), C21H19Cl4FeN4O2S
  19. Crystal structure of (4-chlorophenyl)(4-hydroxyphenyl)methanone, C13H9ClO2
  20. Crystal structure of 6,6′-((pentane-1,3-diylbis(azaneylylidene))bis(methaneylylidene))bis(2,4-dibromolphenolato-κ4 N,N′,O,O′)copper(II),) C19H16Br4CuN2O2
  21. Chlorido-(2,2′-(ethane-bis(5-methoxyphenolato))-κ4 N,N′,O,O′)manganese(III) monohydrate, C19H18Cl2CuN2O2
  22. Crystal structure of 2,6-di-tert-butyl-4-(4-methoxybenzylidene)cyclohexa-2,5-dien-1-one, C22H28O2
  23. Crystal structure of [6,6′-(((2,2-dimethylpropane-1,3-diyl)bis(azanylylidene))bis(methanylylidene))bis(2-chlorophenolato)-κ4N,N′,O,O′]copper(II)
  24. Crystal structure of 2-chloro-3-((thiophen-2-ylmethyl)amino)naphthalene-1,4-dione, C30H20O4N2Cl2S2
  25. Crystal structure of bis{hydridotris(3-trifluoromethyl-5-methylpyrazolyl-1-yl)borato-κN 3}manganese(II), C30H26B2F18MnN12
  26. Crystal structure of 1-(2-methylphenyl)-2-(2-methylbenzo[b]thienyl)-3,3,4,4,5,5-hexafluorocyclopent-ene, C21H14F6S
  27. Crystal structure of 2-(3-((carbamimidoylthio)methyl)benzyl)isothiouronium hexafluorophosphate monohydrate, C10H17F6N4OPS2
  28. Crystal structure of 4,5-diiodo-1,3-dimesityl-1H-1,2,3-triazol-3-ium chloride – chloroform (1/1), C21H23Cl4I2N3
  29. Crystal structure of azido-k1 N-{6,6′-((((methylazanediyl)bis(propane-3,1-diyl))bis(azanylylidene))bis(methanylylidene))bis(2,4-dibromophenolato)k5 N,N′,N″,O,O′}cobalt(III)-methanol (1/1)), C21H23Br4CoN6O3
  30. The crystal structure of 2-(4-((carbamimidoylthio)methyl)benzyl)isothiouronium hexafluorophosphate monohydrate, C10H17F6N4OPS2
  31. Crystal structure of 1,1′-(methane-1,1-diyl)bis(3-methyl-1H-imidazol-3-ium) bis(hexafluoridophosphate), C9H14F12N4P2
  32. Crystal structure of (4′E)-6′-(diethylamino)-2-[(E)-[(pyren-1-yl)methylidene]amino]-4′-{2-[(2E)-1,3,3-trimethyl-2,3-dihydro-1H-indol-2-ylidene]ethylidene}-1′,2,2′,3,3′,4′-hexahydrospiro[isoindole-1,9′-xanthene]-3-one, C54H48N4O2
  33. Crystal structure of poly[bis(μ2-2,6-bis(1-imidazoly)pyridine-κ2 N,N′)-bis(thiocyanato-κ1 N)copper(II)] dithiocyanate, C24H18CuN12S2
  34. Cones with a three-fold symmetry constructed from three hydrogen bonded theophyllinium cations that coat [FeCl4]− anions in the crystal structure of tris(theophyllinium) bis(tetrachloridoferrate(III)) chloride trihydrate, C21H33Cl9Fe2N12O9
  35. Crystal structure of 14-O-[(4-(4-hydroxypiperidine-1-yl)-6-methylpyrimidine-2-yl)thioacetyl]-mutilin monohydrate, C32H49N3O6S
  36. The crystal structure of (E)-3-chloro-2-(2-(4-methylbenzylidene)hydrazinyl)pyridine, C13H12ClN3
  37. The crystal structure of 4-phenyl-4-[2-(pyridine-4-carbonyl)hydrazinylidene]butanoic acid, C16H15N3O3
  38. The crystal structure of 6-amino-5-carboxypyridin-1-ium pentaiodide monohydrate C6H9I5N2O3
  39. Crystal structure of bis(μ3-oxido)-bis(μ2-2-formylbenzoato-k2O:O′)-bis(2-(dimethoxymethyl)-benzoato-κO)-oktakismethyl-tetratin(IV)
  40. Crystal structure of 2-((E)-(((E)-2-hydroxy-4-methylbenzylidene) hydrazineylidene)methyl)-4-methylphenol, C16H16N2O2
  41. Crystal structure of (E)-amino(2-((5-methylfuran-2-yl)methylene)hydrazinyl) methaniminium nitrate monohydrate, C14H26N10O10
  42. The crystal structure of N′-(2-chloro-6-hydroxybenzylidene)thiophene-2-carbohydrazide monohydrate, C12H11ClN2O3S
  43. Crystal structure of catena-poly[(μ2-1,1′-(biphenyl-4,4′-diyl)bis(1H-imidazol)-κ2N:N′)-bis(4-bromobenzoate-κ1O)zinc(II)], C64H44Br4N8O8Zn2
  44. The crystal structure of catena-poly[(1-(4-carboxybenzyl)pyridin-1-ium-4-carboxylato-κ1O)-(μ2-oxalato-κ4 O:O′:O″:O‴)dioxidouranium(VI)], C16H11NO10U
  45. Crystal structure of 3-allyl-4-(2-bromoethyl)-5-(4-methoxyphenyl)-2-phenylfuran, C22H21BrO2
  46. Halogen bonds in the crystal structure of 4,3′:5′,4″-terpyridine — 1,3-diiodotetrafluorobenzene (1/1), C21H11F4I2N3
  47. Crystal structure of 2-(1H-indol-3-yl)ethan-1-aminium 2-(4-acetylphenoxy)acetate, C20H22N2O4
  48. Chalcogen bonds in the crystal structure of 4,7-dibromo-2,1,3-benzoselenadiazole, C6H2Br2N2Se
  49. The crystal structure of 1,4-bis((1H-benzimidazol-2-yl)methyl)-piperazine-2,5-dione dihydrate, C20H22N6O4
  50. The crystal structure of C19H20O8
  51. The crystal structure of KNa3Te8O18·5H2O exhibiting a ∞2[Te4O9]2− layer
  52. Erratum
  53. Erratum to: Crystal structure of (Z)-3-(6-bromo-1H-indol-3-yl)-1,3-diphenylprop-2-en-1-one, C23H16BrNO
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 5.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2021-0360/html?licenseType=open-access
Scroll to top button